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ABSTRACT 
A  series  of  newly  synthesized  organotin  (IV)  with  N-alkyl-N-phenyldithiocarbamate  ligands  namely 
triphenyltin  (IV)  ethylphenyldithiocarbamate  (compound  1)  and  triphenyltin  (IV) 
butylphenyldithiocarbamate (compound 2) were assessed for their cytotoxic effect against HT-29 human 
colon  adenocarcinoma  cells  and  human  CCD-18Co  normal  colon  cells.    The  cytotoxicity  of  these 
organotins  in  both  cells  was  assessed  using  3-(4,5-dimethylthiazol-2-yl)-2,  5-diphenyltetrazholium 
bromide (MTT) assay upon 24 h treatment. Both compounds demonstrated potent cytotoxicity towards 
HT-29 cells with the IC50 of 0.18 µM for compound 1 and 0.20 µM for compound 2. Interestingly, 
compound 1 exhibited lower cytotoxicity towards CCD-18Co with IC50 of 1.55 µM whereas no IC50 was 
detected for compound 2 up to 2 µM treatment. The mode of cell death was determined based on the 
externalization  of  phosphatidylserine  using  flow  cytometry.  Cells  treated  with  compound  1  and 
compound 2 were mainly viable and the apoptotic cell death was around 10% which suggests that both 
compounds induced growth arrest. In conclusion, this study demonstrated that both compounds were 
selective towards human colorectal cells by giving a strong cytotoxicity to cancer cells and low toxicity 
towards normal cells. Both compounds were suggested to induce growth arrest in HT-29 cells. 
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1.  INTRODUCTION 
The  world  cancer  statistic  in  2008  has  estimated 
12.66  million  people  were  diagnosed  with  cancer. 
Among all types of cancers, colorectal cancer being the 
third  most  commonly  diagnosed  malignancy.  An 
approximately  1.24  million  people  were  suffered  with 
this type of cancer throughout the year, accounting for 
10% of overall cancer cases Cancer Research UK, 2011. 
The mortality resulted from  cancers  were 7.56 million 
whereby the colorectal cancer was ranked as the fourth 
most  common  cause  of  cancer-related  death  in  2008 
Cancer Research UK, 2011 (Sasaki et al., 2010). 
The  increase  number  of  human  population  will 
proportionally increase theincidence of cancer although 
the rates of current cancer incidence remain consistent 
Cancer  Research  UK,  2011.  Therefore,  the  effective 
ways  to  combat  the  disease,  specifically  colorectal 
cancerare  crucially  needed  and  many  researchers  are 
currently paying a great attention into this matter. The 
current treatment used forcolorectal cancers are surgery, 
chemotherapy,  radiation  therapy  and  targeted  therapies 
(Hagan et al., 2013). Taken together, surgery excision 
remains as a basis for cancer treatment especially at the 
early  stages  of  colorectal  cancer  (Hagan  et  al.,  2013). 
Apart from that, chemotherapy is also recognized as one 
of the effective  method used to treat colorectal cancer 
patients (Hagan et al., 2013; Tong et al., 2011). Several 
chemotherapeutic  drugs  usedin  colorectal  cancer 
treatment  are  5-Fluorouracil  (5-FU),  bevacizumab, 
cetuximab  and  oxaliplatin  (NCI,  2013;  Hagan  et  al., 
2013). Among these, 5-FU have been the main options Normah Awang et al. / OnLine Journal of Biological Sciences 14 (2): 84-93, 2014 
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for chemotherapyin patients with stage II, III and IV of 
colorectal cancer (ACS, 2013). 
Unfortunately, the colorectal cancer cells have been 
identified  to  become  resistance  in  response  to  5-FU 
treatment.  In addition, there were some cases reported 
the toxicity caused by  this drugon normal cells. These 
have  become  a  major  problem  to  ensure  a  successful 
chemotherapy  among  colorectal  cancer  patients 
(Srimuangwong  et  al.,  2012).  Therefore,  more  effective 
anticancer agents are subjected to be developed in order to 
treat  this  type  of  cancer.  Many  studies  are  currently 
focusing  on  other  alternatives  to  find  the  most  effective 
way to enhance the efficacy of  5-FU, as well as to reduce 
its  toxicity  towards  normal  cells  (Srimuangwong  et  al., 
2012). Hence, some approaches have been introduced to 
overcome these problems including the combination of 5-
FU with other drugs or new compounds (Srimuangwong 
et al., 2012). On the other hands, the newly synthesized 
compounds  are  also  suggested  as  the  potential 
chemotherapy drugs and being investigated worldwide.  
The  synthesized  organotin  derivatives  have  been 
identified as one of the promising candidates to combat 
cancers  (Alama  et  al.,  2009).  They  are  getting  more 
attentions  due  to  their  diverse  structures  and  potent 
biological activities (Shahzadi et al., 2006). Interestingly, 
the organotinbiological activities are greatly influenced 
by their various molecular structures and most of them 
are generally very toxic even at very low concentrations 
(Pellerito et al., 2006). Previous studies by (Gielen et al., 
2000; Abdellah et al., 2009) using organotin derivatives 
had  shown  a  significant  cytotoxicity  and  anticancer 
properties  against  various  types  of  human  cancerous 
cells  in  in  vitro  studies  including  HT-29  colon 
adenocarcinoma cells (Girasolo et al., 2010). All novel 
organotin  (IV)  derivatives,  with  the  exception  of 
dimethyltin (IV), showed significant cytotoxicity in HT-
29 and was suggested to induce cell death via apoptosis 
(Girasolo  et  al.,  2010).  To  date,  the  synthesized  di- 
and tri-n-butyltin (IV) carboxylates derivatives against 
HT-29  colon  adenocarcinoma  cell  line  showed  a 
potent  anticancer  activity  via  the  inhibition  of 
thioredoxin  reductase  at  the  micromolar  range 
(Oliveira et al., 2013). These examples demonstrated 
the  organotin  (IV)  derivatives  as  apromisingand 
potent  new  anticancer  drugs  that  promote  a  new 
dimension in anticancer drugs development. 
In this study, the in vitro cytotoxicity and the mode 
of cell death of the newly synthesized organotin (IV) 
compounds  namely  triphenyltin  (IV) 
ethylphenyldithiocarbamate  (compound  1)  and 
triphenyltin  (IV)  butylphenyldithiocarbamate 
(compound 2) were assessed. The chemical structures 
of  both  compounds  are  shown  in  Fig.  1  and  2.  The 
cytotoxicity  of  both  compounds  were  done  in  HT-29 
colon  adenocarcinoma  cells  and  human  CCD-18Co 
normal  colon  cells.  The  observation  of  cell 
morphological  changes  and  the  mode  of  cell  deathin 
both cells were carried out. 
 
 
 
    Fig. 1. The chemical structure of compound 1 (Kamaludin et al., 2012) Normah Awang et al. / OnLine Journal of Biological Sciences 14 (2): 84-93, 2014 
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Fig.  2. The chemical structure of compound 2 (Kamaludin et al., 2011) 
 
2.  MATERIALS AND METHODS 
2.1. Method for Compounds Synthesis 
Both compounds were synthesized via in-situ method 
using the respective secondary amines, carbon disulphide 
and triphenyltin (IV) chloride salts. The formation of the 
compounds were confirmed via elemental analysis (C,H,N 
and S), infrared and nuclear magnetic resonance (
1H and 
13C)  spectroscopies  and  X-ray  crystallography  study 
(Kamaludin et al., 2011; 2012).  
2.2. Cell Culture and Reagents 
HT-29  human  adenocarcinoma  cells  and  human 
CCD-18Co  normal  colon  cells  wereobtained  from 
American Type Culture Collection (ATCC). The HT-29 
cells were maintained in McCoy’s 5a Modified medium 
containing L-glutamine and 10% Foetal Bovine Serum 
(FBS)  (GIBCO,  USA).  The  CCD-18Co  cells  were 
maintained  in  Eagle’s  Minimum  Essential  Medium 
(MEM)  supplemented  with  sodium  bicarbonate 
(NaHCO3),  1%  sodium  pyruvate,  1%  non-essential 
amino acid, 1% penicillin/streptomycin and 10% Foetal 
Bovine Serum (FBS) (GIBCO, USA). The cell lineswere 
maintained at 37°C in 5% CO2 atmosphere according to 
the recommended protocols by ATCC. 
2.3. MTT Cytotoxicity Assay 
The  viability  of  HT-29  and  CCD-18Co  cells  were 
determined  using  3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazholium  bromide  (MTT)  assay  (Mosmann, 
1983). Cells were seeded in a sterile 96-well microplate at 
a density of 5 10
4 cells mL
-1 and incubated at 37°C in 5% 
CO2for 24 h. Then, the medium in each well was removed 
and  replaced  with  a  fresh  medium  containing  tested 
compounds at various concentrations ranging from 0 to 
2µM.  After 24 h of treatment, 20 µL of 5 mg Ml
1 MTT 
solution was added to each wellprior to 4 h incubation.  
An approximate of 180 µL media in each well was 
removed  and  replaced  with  180  µL  of  DMSO  to 
dissolve  the  crystal  formazan.  After  15  min  of 
incubation, the plate was agitated using orbital shaker 
for  5  min  to  ensure  the  crystal  formazan  was 
completely  dissolved.  The  Optical  Density  (OD)  of 
each well was measured at 570 nm wave length using 
iMark  Microplate  Reader  (BioRad,  USA).  The 
inhibitory  concentration  that  killed  50%  of  cell 
population  (IC50)  was  calculated  and  used  as  a 
parameter to compare the relative cytotoxicity of each 
compound (Thati et al., 2007).  
2.4. Morphological Observation 
Cells were seeded into a sterile 96-well microplate at 
a  density  of  5×10
4  cells  mL
-1  and  allowed  to  attach 
within 24 h at 37°C in 5% CO2. Then, the cells were 
treated with a series of concentrations (0-2 µM) for 24 h. 
Finally,  the  cells  were  observed  under  light  inverted 
microscope at 2000 magnification. Normah Awang et al. / OnLine Journal of Biological Sciences 14 (2): 84-93, 2014 
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2.5. Mode of Cell Death 
Annexin  V-FITC/PI  test  was  employed  to 
distinguish  between  apoptotic  and  necrotic  cells 
according  to  the  method  as  previously  described  by 
Chan et al. (2012) with slight modifications. The HT-
29 cells were seeded into  a sterile 6-well microplate at 
a density of 5×10
4 cells mL
-1. After 24 h of incubation, 
the  cells  were  treated  with  both  compounds  at  IC50 
concentrations and further incubated for 24 h. Then, the 
media was collected into a centrifuge tube. The chilled 
PBS was used to wash the attached cells and it wasalso 
collected into the tube. The trypsin was added for 1 min 
to  detach  the  cells.  The  trypsinization  was  stopped 
using  the  mediumto  prevent  cell  damages.  The  cells 
suspension were collected into the tube. The cells were 
centrifuged  at  220  g  for  5 min.  The  supernatant  was 
removed.  The  pellet  was  washed  twice  with  chilled 
PBS.Then, the supernatant was discarded and the cells 
were  resuspended  in  100  µL  of  Annexin  V  Binding 
Buffer. The cells were stained with 2.5 µL of Annexin 
V-FITC  (BD  Pharmingen)  for  15  min  at  room 
temperature. Subsequently, 5 µL of Propidium Iodide 
(PI) (50 µg mL
1) was added into the cells and further 
incubated for 2 min. The whole staining process was 
carried  out  in  dark  condition.  Further,  400  µL  of 
Annexin V binding buffer was added into the samples 
and  transferred  into  a  Falcon  tube.  The  cells  were 
analysed  quantitatively  viaBD  facscanto  II  flow 
cytometry (Becton Dickinson, USA). 
2.6. Selectivity Index (SI) 
The degree of selectivity of the compounds can be 
expressed by its SI value as suggested by Badisa et al. 
(2009). 
 
50
50
SI  IC normal 
cellIC cancer cell
=  
 
2.7. Statistical Analysis 
 The data were expressed as the mean±Standard Error of 
Mean  (S.E.M).  Statistical  analysis  was  performed  using 
Statistical Package for Social Sciences (SPSS) version 17.0 
by employing one-way ANOVA. The data wereconsidered 
statistically significant when p<0.05. 
3.  RESULTS 
3.1.  Cytotoxicity of Triphenyltin (IV) N-alkyl-N-
Phenyldithiocarbamate Compounds in HT-
29 and CCD-18Co Cells 
Both  compounds  showed  highcytotoxicity  towards 
HT-29  cellsin  concentration  dependent  manner  (Fig.  3). 
The IC50 of compound 1 was 0.18 µM whereas the IC50 
value for compound 2 was 0.20 µM. This showed that the 
HT-29 cell line had higher sensitivity towards compound 
1as compared to compound 2. The statistical analysis for 
both  compounds  showed  significant  differences  between 
the  percentage  of  viability  of  treated  and  untreated  cells 
(p<0.05) at all concentrations except 0.031 µM and 0.063 
µM for compound 1 and compound 2, respectively. 
In contrast to HT-29, only compound 1 gave high 
cytotoxicity  towards  CCD-18Co  cells  with  IC50 
valueof  1.55  µM  upon  24  h  of  treatment  (Fig.  4). 
There was no IC50 value given by compound 2 up to 2 
µM  treatment.  However,  the  statistical  analysis  for 
compound 1 and 2 showed that the percentage of cell 
viability for treated cells from 0.25 µM-2.00 µM and 
0.5  µM-2.00  µM  were  significantly  difference 
(p<0.05) compared to the percentage of cell viability 
exhibited by untreated cells, respectively. 
3.2. Selectivity Index (SI)  
Both    compounds  showedgood  selectivity  against 
HT-29  and  CCD-18Co  cell  lines  with  the  SI  value  of 
more  than  2  (Table  1).  High  SI  value  (>2)  of  a 
compound gives a selective toxicity towards cancer cells. 
While the compound with SI value <2 is considered to 
give  general  toxicity  in  which  it  also  can  cause 
cytotoxicity in normal cells (Badisa et al., 2009). 
3.3. Morphological  Changes  of  HT-29  Cells 
Induced  by  Triphenyltin  (IV)  N-alkyl-N-
Phenyldithiocarbamate 
The observation of cells  morphology changes  were 
assesed using the different concentration of compounds 
upon 24 h treatment (Fig. 5).  The result of observation 
showed  that  the  cells  were  treated  using  the  highest 
concentration up to 2µM, the cell  become shrink and 
formation  of  apoptotic  bodies  whereas  no  significant 
difference with the untreated cells when the cells were 
exposed to the lowest concentration 0.031µM.  
3.3.1. Mode of Cell Death on HT-29 Cells Upon 
Treated with Triphenyltin (IV) N-alkyl-N-
Phenyldithiocarbamate 
The  percentage  of  the  externalization  of 
phosphatidylserine  in  HT-29  cells,  treated  with  IC50 
concentration  of  both  compounds  showed  that  the 
percentage  of  cells  died  via  apoptosis  were  less  than 
10%, whereby the total cell death were less than 12% 
(Fig. 6). The cells were mainly viable and there was no 
significant difference among the percentage of live cells 
in treated and untreated cells. Normah Awang et al. / OnLine Journal of Biological Sciences 14 (2): 84-93, 2014 
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Table 1.  Selectivity Index (SI) for compound 1 and compound 2 
  Compound 1  Compound 2 
IC50, CCD-18Co  1.55 µM  >2.00 µM 
IC50, HT-29  0.18 µM  0.20 µM 
SI  8.61   >10 
 
 
 
Fig. 3. The cytotoxicity of compound 1 and 2against HT-29 cells upon 24 h of treatment using MTT assay. Data represent the mean 
(± SEM) of at least three independent experiments 
 
 
 
Fig. 4. The cytotoxicity of compound 1 and 2 against CCD-18°C cells upon 24 h of treatment using MTT assay. Data represent the 
mean (±SEM) of at least three independent experiments Normah Awang et al. / OnLine Journal of Biological Sciences 14 (2): 84-93, 2014 
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  (a)  (b)  (c) 
 
 
  (d)  (e)  (f) 
 
 
  (g)  (h)  (i) 
 
 
  (j)  (k)  (l) 
 
 
  (m)  (n)  (o) 
 
Fig. 5. Morphological observations of HT-29 cells upon 24 h of treatment of compound 1 (b-h) and compound 2 (i-o) using 7 
different  concentrations  at  20X  magnification.  (a)  Represents  the  untreated  cells.  Both  compounds  induced 
morphological changes in HT-29 cells. The morphological changes that can be observed included cell shrinkage, cells 
became rounded and cells lysis Normah Awang et al. / OnLine Journal of Biological Sciences 14 (2): 84-93, 2014 
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Fig. 6. The  percentage  of  viable,  apoptotic  and  necrotic  cells  in  HT-29  cells  upon  treated  with  compound  1  and  2  at  IC50 
concentration for 24 h. Data represent the mean (± SEM) of at least three independent experiments 
 
4.  DISCUSSION 
The  organotin  derivatives  are  greatly  being 
synthesized  and  their  anticancer  properties  are 
extensively being studied. Organotin compounds have 
shown  a  marked  cytotoxicity  in  various  types  of  cell 
lines of human and animal  origins. Several organotin 
compounds  synthesized  by  our  group  also  showed 
significant  cytotoxicity  towards  HepG2 
hepatocarcinoma,  Jurkat  T  lymphoblastic,  chronic 
myelogenous  leukemia  (K562)  and  thymoma  murine 
(WEHI  7.2)  cell  lines  (Kamaludin  et  al.,  2013). 
Previous  finding  showed  that  organotin  (IV) 
dithiocarbamate  compounds  displayed  high  toxicity 
towards  Jurkat  T  lymphoblastic  and  K562  cells  with 
IC50  values  of  less  than  9.2  µM  (Kamaludin  et  al., 
2013).  Therefore,  they  were  classified  as  very  toxic 
compounds (How et al., 2008).  
Similarly,  the  triphenyltin  (IV)  N-alkyl-N-
phenyldithiocarbamate  compounds  could  also  be 
classified as very toxic due to their efficacy to inhibit 
the growth of HT-29 cell's population as low as 0.18 
µM.  However,  in  CCD-18Co  cells,  high  cytotoxicity 
was only given by compound 1 with IC50 value of 1.55 
µM.  Compound  2  was  expected  to  give  median 
inhibitory  concentration  above  2.00  µM.  Both 
compounds gave cytotoxicity in HT-29 and CCD-18Co 
cells  whereby  the  higher  cytotoxicity  was  reported  by 
compound  1.  This  study  suggested  that  the  molecular 
structure  of  a  compound  plays  a  significant  role  in 
determining its cytotoxicity. The shorter length of alkyl 
substitution group in a compound increases its cytotoxicity 
(Biplob  et  al.,  2008;  Ray  et  al.,  2000).  This  probably 
explained our finding that showed higher cytotoxicity of 
compound with ethyl group compared to butyl group in 
dithiocarbamate ligand, respectively.  
Due  to  the  different  cytotoxicity  exerted  by  both 
compounds,  the  Selectivity  Index  (SI)  was  measured  to 
determine their selectivity property (Machana et al., 2011; 
Badisa et al., 2009). Both compounds had good selectivity 
against  cancer  cells  with  the  SI  values  higher  than  2. 
However,  the  SI  value  of  compound  2  was  greater  than 
compound 1. This indicated that compound 2probably more 
suitable to be further studied as a potent anticancer drug. 
To  further  evaluated  the  cell  changes  upon 
treatment,  the  cell  morphological  observation  was 
conducted in HT-29 cells. The morphological changes 
of  the  cells  were  detected  to  be  varied  in 
concentration-dependent  manner.  Slight 
morphological changes were found at 0.03125 µM and 
0.0625  µM.  Whilst,  at  0.125  µM  concentration,  the 
cells  began  to  appear  in  visibly  different  form  as Normah Awang et al. / OnLine Journal of Biological Sciences 14 (2): 84-93, 2014 
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compared  to  control.  The  cells  started  losing  their 
shape  with  more  intercell  spaces  were 
observed.Gradually,  with  the  increment  of  treatment 
concentrations,  the  cells  changed  to  round  shaped 
cells and getting smaller in size or shrinked. At 2.00 
µM  concentration,  dead  cells  floated  and  dirty 
background  were  observed  suggesting  the  cells 
lysed.Cell  shrinkage  resembles  the  apoptotic 
characteristic  (Pellerito  et  al.,  2006),  thus  we 
suggested that the cells died via apoptosis. 
To  further  confirm  the  mode  of  cell  death,  the 
Annexin V-FITC/PI test was conducted to determine the 
percentage of the cells death, either through apoptosis 
or  necrosis.  Apoptotic  cell death  is  accompanied  by 
the  translocation  of  Phosphatidylserine  (PS)  from 
inner  to  the  outer  part  of  the  plasma  membrane 
thereby exposing PS to the external cellular activity 
(Alabsi et al., 2012). The binding ability of Annexin 
V to plasma membrane containing PS in the presence 
of  calcium ion (Ca
2+) indicates that the cells died via 
apoptosis (Engeland et al., 1998).  
In  this  study,  both  compounds  gave  only  small 
percentage of cells death which were less than 12% of 
overall cell death after treated with IC50 values of both 
compounds  within  24  h.  These  results  displayed 
inconsistent trend with the IC50 values obtained from the 
MTT assay. More than 80% of cells  were detected as 
viable in Annexin V-FITC/PI assay as compared to the 
50% cells viability as expected from MTT assay results. 
Hence,  these  data  demonstrated  that  the  different 
endpoints being assessed by two different methods would 
greatly  influence  the  experimental  data  (Chan  et  al., 
2006). The measurement of cell viability using MTT 
assay is based on reduction of tetrazholium salt by the 
mitochondrial  succinate  dehydrogenase  enzyme  to 
form crystal formazan, while the measurement of cell 
death in Annexin V-FITC/PI method is dependent on 
the  integrity  of  plasma  membrane  (Mosmann,  1983; 
Engeland et al., 1998). 
Based on the mode of cell death assessment, this 
study suggested that the cytotoxic effects exerted by 
these compounds were not by directly killing the cells, 
but most probably due to the growth inhibitory effects 
of  HT-29  cells  at  the  cell  cycle  level.  Within  this 
cycle, there is a phase known as Go phase whereby no 
proliferation occurs in living cells and the cells will 
leave the cycle temporarily (Pratt, 1994). This could 
be the possible reason to the observation made in this 
study whereby the HT-29 cells were still alive upon 
treated with IC50 concentration, which could be due to 
the cells were in resting phase. Hence, the percentages 
of  dead  cells  were  less  than  50%  in  HT-29  cells 
treated  with  IC50  concentration  of  both  compounds, 
suggesting that both compounds might act through the 
inhibition  of  cell  proliferation  instead  of  killing  the 
cells.  
5.  CONCLUSION 
The  triphenyltin  (IV)  N-alkyl-N-
phenyldithiocarbamate  compounds  demonstrated  a 
strong  cytotoxicity  in  HT-29  cells  and  showed  good 
selectivity  between  HT-29  and  CCD-18Co  cells.  In 
comparison between these compounds, the triphenyltin 
(IV)  butylphenyldithiocarbamate  (compound  2)  was 
found  to  be  more  selective  on  cancer  cells  than 
triphenyltin  (IV)  ethylphenyldithiocarbamate 
(compound  1).  However,  the  efficacy  of  both 
compounds to kill the HT-29 cells were not as expected 
whereby  more  than  80%  of  cells  were  remain  viable 
upon  treated  using  the  IC50  concentration.  Hence,  this 
study  suggested  that  both  compounds  induced  growth 
arrest  in  HT-29  cells  due  to  the  lower  percentage  of 
apoptotic cell death. 
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